Johnson Matthey PLC (LON:JMAT – Get Free Report) shares reached a new 52-week low during trading on Friday . The company traded as low as GBX 1,312 ($16.24) and last traded at GBX 1,315.29 ($16.28), with a volume of 1451411 shares trading hands. The stock had previously closed at GBX 1,337 ($16.55).
Analyst Upgrades and Downgrades
JMAT has been the subject of a number of research reports. Berenberg Bank lowered their target price on Johnson Matthey from GBX 1,650 ($20.42) to GBX 1,500 ($18.57) and set a “hold” rating for the company in a report on Thursday, November 28th. Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.28) target price on shares of Johnson Matthey in a report on Tuesday, December 17th.
Get Our Latest Research Report on Johnson Matthey
Johnson Matthey Price Performance
Johnson Matthey Cuts Dividend
The business also recently disclosed a dividend, which will be paid on Tuesday, February 4th. Stockholders of record on Thursday, December 5th will be given a dividend of GBX 22 ($0.27) per share. The ex-dividend date is Thursday, December 5th. This represents a dividend yield of 1.47%. Johnson Matthey’s dividend payout ratio (DPR) is presently 13,275.86%.
Insider Buying and Selling at Johnson Matthey
In other news, insider Liam Condon bought 27 shares of Johnson Matthey stock in a transaction dated Wednesday, October 16th. The stock was purchased at an average price of GBX 1,505 ($18.63) per share, for a total transaction of £406.35 ($502.97). Also, insider Stephen Oxley acquired 24 shares of the firm’s stock in a transaction on Wednesday, November 20th. The stock was purchased at an average price of GBX 1,504 ($18.62) per share, with a total value of £360.96 ($446.79). Over the last quarter, insiders bought 7,458 shares of company stock valued at $10,024,332. Company insiders own 0.61% of the company’s stock.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
See Also
- Five stocks we like better than Johnson Matthey
- What is a SEC Filing?
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- What is the Hang Seng index?
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.